Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study

…, M Soneja, A Mittal, S Naik, P Kodan… - The Lancet Infectious …, 2022 - thelancet.com
Background BBV152 is a whole-virion inactivated SARS-CoV-2 vaccine that has been
deployed in India. The results of the phase 3 trial have shown clinical efficacy of BBV152. We …

Post COVID-19 sequelae: A prospective observational study from Northern India

…, J Kirtana, A Gupta, D Patidar, P Kodan… - Drug discoveries & …, 2021 - jstage.jst.go.jp
Post COVID-19 sequelae are a constellation of symptoms often reported after recovering
from COVID-19. There is a need to better understand the clinical spectrum and long-term …

Risk factors for Coronavirus disease-associated mucormycosis

…, V Arora, A Ramprasad, A Kumar, RK Garg, P Kodan… - Journal of Infection, 2022 - Elsevier
Background The epidemiology of the Coronavirus-disease associated mucormycosis (CAM)
syndemic is poorly elucidated. We aimed to identify risk factors that may explain the burden …

Nipah virus disease: A rare and intractable disease

S Banerjee, N Gupta, P Kodan, A Mittal… - Intractable & rare …, 2019 - jstage.jst.go.jp
Nipah virus, an enveloped ribonucleic acid virus, has been a major cause of encephalitis
outbreaks with high mortality, primarily in the Indo-Bangladesh regions. Except for the first …

Battling COVID-19: using old weapons for a new enemy

R Kumar, N Gupta, P Kodan, A Mittal, M Soneja… - … , Travel Medicine and …, 2020 - Springer
Coronavirus disease-19 (COVID-19) has reached pandemic proportions. Most of the drugs
that are being tried for the treatment have not been evaluated in any randomized controlled …

Zika virus in India: past, present and future

N Gupta, P Kodan, K Baruah, M Soneja… - QJM: An International …, 2023 - academic.oup.com
Zika virus (ZIKV) is an arthropod-borne flavivirus that presents with acute febrile illness
associated with rash, arthralgia and conjunctivitis. After years of sporadic reports in Africa, the …

COVID‐19‐associated subacute invasive pulmonary aspergillosis

…, R Sarda, S Vyas, G Singh, P Jorwal, P Kodan… - Mycoses, 2022 - Wiley Online Library
Background Though invasive pulmonary aspergillosis is a well known complication of
COVID‐19 pneumonia, indolent forms of aspergillosis have been rarely described. Methods We …

[HTML][HTML] Current and new drugs for COVID-19 treatment and its effects on the liver

S Satsangi, N Gupta, P Kodan - Journal of Clinical and …, 2021 - ncbi.nlm.nih.gov
Corona virus disease (COVID)-19 is caused by the novel severe acute respiratory syndrome
coronavirus-2 (commonly referred to as SARS-CoV-2). In March 2020, the World Health …

[HTML][HTML] Association of dengue virus and leptospira co-infections with malaria severity

…, C Kaur, A Pramanik, V Kumar, P Kodan… - Emerging infectious …, 2020 - ncbi.nlm.nih.gov
Plasmodium infections are co-endemic with infections caused by other agents of acute febrile
illnesses, such as dengue virus (DENV), chikungunya virus, Leptospira spp., and Orientia …

Intricate interplay between Covid‐19 and cardiovascular diseases

VC Keri, A Hooda, P Kodan, B RL… - Reviews in Medical …, 2021 - Wiley Online Library
Covid‐19 disease can involve any organ system leading to myriad manifestations and
complications. Cardiovascular manifestations are being increasingly recognised with the …